Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders

NCT ID: NCT02735473 Phase: PHASE2 Status: COMPLETED Enrollment: 46 Completion: 2021-09-10

Conditions

Fetal Alcohol Spectrum Disorders

Interventions

Choline bitartrate, Placebo

Summary

This is a randomized, double-blind, placebo-controlled trial of choline supplementation in children with Fetal Alcohol Spectrum Disorders (FASD). The primary outcome measures are cognitive measures.

Primary Outcome

Elicited Imitation Memory Task - Short Delay Memory Measure: 6 Months

Source

ClinicalTrials.gov